Evidence map›Paper›PMID 32668225›Full record

ArticleImmunity2020

An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity.

David R Glass, Albert G Tsai, John Paul Oliveria, Felix J Hartmann, Samuel C Kimmey, Ariel A Calderon, Luciene Borges, Marla C Glass, Lisa E Wagar, Mark M Davis and 1 more

Abstract read
In one paragraph

Article in Immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David R GlassImmunology Graduate Program, Stanford University, Stanford, CA, 94305, USA; Department of Pathology, Stanford University, Stanford, CA, 94305, USA.
Albert G TsaiDepartment of Pathology, Stanford University, Stanford, CA, 94305, USA.
John Paul OliveriaDepartment of Pathology, Stanford University, Stanford, CA, 94305, USA; Department of Medicine, Division of Respirology, McMaster University, Hamilton, ON, L8S4K1, Canada.
Felix J HartmannDepartment of Pathology, Stanford University, Stanford, CA, 94305, USA.
Samuel C KimmeyDepartment of Pathology, Stanford University, Stanford, CA, 94305, USA; Department of Developmental Biology, Stanford University, Stanford CA, 94305, USA.
Ariel A CalderonImmunology Graduate Program, Stanford University, Stanford, CA, 94305, USA; Department of Pathology, Stanford University, Stanford, CA, 94305, USA.
Luciene BorgesDepartment of Pathology, Stanford University, Stanford, CA, 94305, USA.
Marla C GlassDepartment of Surgery, Stanford University, Stanford CA, 94305, USA.
Lisa E WagarDepartment of Microbiology and Immunology, Stanford University, Stanford CA, 94305, USA.
Mark M DavisDepartment of Microbiology and Immunology, Stanford University, Stanford CA, 94305, USA.
Sean C BendallImmunology Graduate Program, Stanford University, Stanford, CA, 94305, USA; Department of Pathology, Stanford University, Stanford, CA, 94305, USA. Electronic address: bendall@stanford.edu.

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)U24CA224309 · NCI · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Holden T. Maecker · 2017 to 2026
$19.9M
Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL, MONTINE, THOMAS J · 2020 to 2024
$15.9M
Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R, KUO, CALVIN J · 2015 to 2025
$13.5M
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers DiseaseR01AG057915 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$4.5M
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam ImagingR01AG056287 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$2.6M
REGULATION OF PHAGOCYTE FUNCTIONR01AI035947 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI KNAUS, ULLA G. · 1994 to 2006
$2.5M
Origins of human blood lineages in regenerative medicineDP2EB024246 · NIBIB · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2016 to 2016
$2.4M
A robust platform for multiplexed, subcellular proteomic imaging in human tissueUH3CA246633 · NCI · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2019 to 2021
$1.8M
A single-cell platform to discover and study regulators of human developmentR00GM104148 · NIGMS · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2014 to 2016
$747k
NCI NIH HHS U24 CA224309NCI NIH HHS UH3 CA246633NIAID NIH HHS R01 AI035947NIAID NIH HHS T32 AI007290NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI116484NIA NIH HHS R01 AG056287NIA NIH HHS R01 AG057915NIA NIH HHS U19 AG065156NIBIB NIH HHS DP2 EB024246NIGMS NIH HHS R00 GM104148NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

B cells are capable of a wide range of effector functions including antibody secretion, antigen presentation, cytokine production, and generation of immunological memory. A consistent strategy for classifying human B cells by using surface molecules is essential to harness this functional diversity for clinical translation. We developed a highly multiplexed screen to quantify the co-expression of 351 surface molecules on millions of human B cells. We identified differentially expressed molecules and aligned their variance with isotype usage, VDJ sequence, metabolic profile, biosynthesis activity, and signaling response. Based on these analyses, we propose a classification scheme to segregate B cells from four lymphoid tissues into twelve unique subsets, including a CD45RB

Indexed as

5'-NucleotidaseApyraseB-Lymphocyte SubsetsCD11c Antigenfas ReceptorFemaleGPI-Linked ProteinsHumansImmunoglobulin IsotypesImmunologic MemoryLeukocyte Common AntigensMembrane ProteinsMiddle AgedSignal Transduction5'-NucleotidaseApyraseCD11c AntigenENTPD1 protein, humanFAS protein, humanfas ReceptorGPI-Linked ProteinsImmunoglobulin IsotypesLeukocyte Common AntigensMembrane ProteinsNT5E protein, humanB cellscell atlashumanmass cytometrymulti-omicsingle cell

Identifiers

PMID32668225
PMCPMC7369630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.